Home -
Products -
Others -
Other Targets -
1-O-[β-D-Xylopyranosyl-(1-6)-β-D-glucopyranosyl]-8-hydroxy-3,7-dimethoxyxanthone
1-O-[β-D-Xylopyranosyl-(1-6)-β-D-glucopyranosyl]-8-hydroxy-3,7-dimethoxyxanthone
CAS No. 60354-05-4
1-O-[β-D-Xylopyranosyl-(1-6)-β-D-glucopyranosyl]-8-hydroxy-3,7-dimethoxyxanthone( ——— )
Catalog No. M38382 CAS No. 60354-05-4
α-Glucosidase-IN-24 (Compound 13) is an α-Glucosidase inhibitor with an IC50 of 451 μM. α-Glucosidase-IN-24 can be isolated from Swertia kouitchensis.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 25MG | Get Quote | Get Quote |
|
| 50MG | Get Quote | Get Quote |
|
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product Name1-O-[β-D-Xylopyranosyl-(1-6)-β-D-glucopyranosyl]-8-hydroxy-3,7-dimethoxyxanthone
-
NoteResearch use only, not for human use.
-
Brief Descriptionα-Glucosidase-IN-24 (Compound 13) is an α-Glucosidase inhibitor with an IC50 of 451 μM. α-Glucosidase-IN-24 can be isolated from Swertia kouitchensis.
-
Descriptionα-Glucosidase-IN-24 (Compound 13) is an α-Glucosidase inhibitor with an IC50 of 451 μM. α-Glucosidase-IN-24 can be isolated from Swertia kouitchensis.
-
In Vitro———
-
In Vivo———
-
Synonyms———
-
PathwayOthers
-
TargetOther Targets
-
RecptorIC50: 451 μM (α-Glucosidase)
-
Research Area———
-
Indication———
Chemical Information
-
CAS Number60354-05-4
-
Formula Weight582.51
-
Molecular FormulaC26H30O15
-
Purity>98% (HPLC)
-
Solubility———
-
SMILES———
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Wan LS, et al. Xanthone glycoside constituents of Swertia kouitchensis with α-glucosidase inhibitory activity. J Nat Prod. 2013 Jul 26;76(7):1248-53.?
molnova catalog
related products
-
PGLa TFA
PGLa TFA is a cationic antimicrobial peptide (AMP) originally isolated from frog. It has been shown to have antibacterial,antifungal,and antiviral,activities.
-
PF-04937319
PF-04937319 is an activator of glucokinase (EC50 =154.4 ?μM). PF-04937319 maintains glucose-lowering efficacy while mitigating the risk of hypoglycemia observed with many other glucokinase activators. PF-04937319 can be used in research on the treatment of type 2 diabetes mellitus.
-
Anemarrhenasaponin I
Anemarrhenasaponin I shows the remarkable inhibiting effect on platelet aggregation.
Cart
sales@molnova.com